ICCM Relative Valuation
ICCM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ICCM is overvalued; if below, it's undervalued.
Historical Valuation
Icecure Medical Ltd (ICCM) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -5.36. The fair price of Icecure Medical Ltd (ICCM) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：0.69
Fair
-6.39
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Icecure Medical Ltd. (ICCM) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
-2.37
EV/EBIT
Icecure Medical Ltd. (ICCM) has a current EV/EBIT of -2.37. The 5-year average EV/EBIT is -4.52. The thresholds are as follows: Strongly Undervalued below -19.13, Undervalued between -19.13 and -11.83, Fairly Valued between 2.78 and -11.83, Overvalued between 2.78 and 10.08, and Strongly Overvalued above 10.08. The current Forward EV/EBIT of -2.37 falls within the Historic Trend Line -Fairly Valued range.
4.46
PS
Icecure Medical Ltd. (ICCM) has a current PS of 4.46. The 5-year average PS is 14.82. The thresholds are as follows: Strongly Undervalued below -15.74, Undervalued between -15.74 and -0.46, Fairly Valued between 30.10 and -0.46, Overvalued between 30.10 and 45.38, and Strongly Overvalued above 45.38. The current Forward PS of 4.46 falls within the Historic Trend Line -Fairly Valued range.
-9.20
P/OCF
Icecure Medical Ltd. (ICCM) has a current P/OCF of -9.20. The 5-year average P/OCF is -1.86. The thresholds are as follows: Strongly Undervalued below -7.55, Undervalued between -7.55 and -4.71, Fairly Valued between 0.98 and -4.71, Overvalued between 0.98 and 3.82, and Strongly Overvalued above 3.82. The current Forward P/OCF of -9.20 falls within the Strongly Undervalued range.
-8.88
P/FCF
Icecure Medical Ltd. (ICCM) has a current P/FCF of -8.88. The 5-year average P/FCF is -3.20. The thresholds are as follows: Strongly Undervalued below -8.70, Undervalued between -8.70 and -5.95, Fairly Valued between -0.44 and -5.95, Overvalued between -0.44 and 2.31, and Strongly Overvalued above 2.31. The current Forward P/FCF of -8.88 falls within the Strongly Undervalued range.
Icecure Medical Ltd (ICCM) has a current Price-to-Book (P/B) ratio of 5.21. Compared to its 3-year average P/B ratio of 5.80 , the current P/B ratio is approximately -10.26% higher. Relative to its 5-year average P/B ratio of 5.74, the current P/B ratio is about -9.21% higher. Icecure Medical Ltd (ICCM) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -27.09%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -25.31% , the current FCF yield is about -100.00% lower.
5.21
P/B
Median3y
5.80
Median5y
5.74
-28.42
FCF Yield
Median3y
-27.09
Median5y
-25.31
Competitors Valuation Multiple
The average P/S ratio for ICCM's competitors is 0.00, providing a benchmark for relative valuation. Icecure Medical Ltd Corp (ICCM) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 28.40%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ICCM decreased by 38.28% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 662.00K to 850.00K.
The secondary factor is the Margin Expansion, contributed -17.86%to the performance.
Overall, the performance of ICCM in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is Icecure Medical Ltd (ICCM) currently overvalued or undervalued?
What is Icecure Medical Ltd (ICCM) fair value?
How does ICCM's valuation metrics compare to the industry average?
What is the current P/B ratio for Icecure Medical Ltd (ICCM) as of Dec 05 2025?
What is the current FCF Yield for Icecure Medical Ltd (ICCM) as of Dec 05 2025?
What is the current Forward P/E ratio for Icecure Medical Ltd (ICCM) as of Dec 05 2025?